Back to search

National and Kapodistrian University of Athens

Κυτταρογενετική και μοριακή μελέτη ασθενών με πρωτοπαθή και δευτεροπαθή οξεία μυελογενή λευχαιμία

Abstract

dc:description

Acute Myelogenous Leukemia (AML) comprise a heterogeneous disease. The etiology of AML development is currently unknown; however, the interaction between environmental exposure and genetic individual’s background has been postulated to be a possible cause for the development of AML. Τhe aim of this thesis was to investigate the role of genetic polymorphisms of the detoxification genes CYP2B6 (G516T, C777A, A785G), GSTP1 (A313G) and DNA repair genes RAD51 (G135C), XPD23 (A23927C) and LIG4 (C26T) in the development of AML. We also investigated the methylation status of the promoter of GSTP1 gene in the development of AML. The study was performed in 619 AML patients and 430 unrelated healthy donors. Research methodology included cytogenetic analysis of bone marrow samples, genotyping analysis of the above mentioned polymorphisms and methylation analysis of the promoter of the GSTP1 gene. The results of this study revealed an increased frequencies of the variant genotypes of G516T and A785G polymorphisms of CYP2B6 gene as well as A313G GSTP1 and C26T LIG4 polymorphism in AML patients compared to controls indicating the possible role of the above polymorphisms in AML susceptibility. In contrast, the polymorphism C777A of CYP2B6 gene and the polymorphisms G135C, A23927C of the repair genes RAD51 and XPD23 respectively, revealed similar frequency distribution between patients and controls, suggesting that probably the presence of these polymorphisms did not increase the risk of AML. Identification of the CYP2B6 haplotypes was also performed. Patients carriers the haplotype TAG (combination of three mutants alleles) have 3-fold increased risk of AML development compared to controls. The association between genotypes of the above genes and cytogenetic results of patients showed statistical differences indicating the significant role of polymorphisms in the formation of specific AML chromosomal aberrations. Furthermore, the promoter of GSTP1 gene was found to be methylated in patients with s-AML. Therefore, the results of this thesis contribute to the understanding of the role of polymorphisms of detoxification and repair genes in susceptibility to AML and the development of specific cytogenetic alterations.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Daraki, Aggeliki
  • Δαράκη, Αγγελική

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37081

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Daraki, Aggeliki; Δαράκη, Αγγελική. Κυτταρογενετική και μοριακή μελέτη ασθενών με πρωτοπαθή και δευτεροπαθή οξεία μυελογενή λευχαιμία. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/37081